Thalia Therapeutics - CEO Interview: Thalia’s RNA Therapeutics Strategy
Reach
Latest announcements
Announcement summary
Thalia Therapeutics - CEO Interview: Thalia’s RNA Therapeutics Strategy
We are pleased to share a conversation with our CEO, Dr David Solomon, offering insight into Thalia Therapeutic's vision, strategy, and opportunities ahead.
Ask a question
Your question will be visible to everyone.
Investor Q&As
Start the conversation
Ask Thalia Therapeutics a question about this announcement.